(Press-News.org) Osaka, Japan – The long-term stasis of blood in the liver, known as chronic liver congestion, can lead to a range of diseases – some of which are fatal. However, identifying how liver congestion causes these diseases has remained unclear, causing difficulty in proposing the best treatment pathway.
In a study recently published in Gastroenterology, Japanese researchers have identified a molecular pathway connecting liver congestion to liver fibrosis, portal hypertension, and liver tumorigenesis. This finding has important implications for potential therapies.
Chronic liver congestion is also known as congestive hepatopathy, and often progresses to liver fibrosis, eventually cirrhosis, and even cancer. Despite these associations being well-established in the literature for a long time, the specific molecular mechanisms that link liver congestion with liver fibrosis remain relatively unknown.
To change this, researchers at The University of Osaka decided to explore these mechanisms to search for potential therapeutic targets that may prevent liver congestion from developing into more severe diseases.
“We focused on a type of liver cell called liver sinusoidal endothelial cells, or LSECs, which form the inner lining of the tiny blood vessels inside the liver and are directly affected when blood flow is blocked or slowed, such as during liver congestion,” says lead author, Seiya Kato. “We used state-of-the-art techniques – single-cell and spatial transcriptomics, which allow us to analyze gene activity in individual cells and their locations within tissues – to study liver samples from a mouse model of congestion and from patients with conditions such as Fontan-associated liver disease. This helped us to uncover how liver congestion triggers changes at the molecular level.”
These analyses revealed increased activity of two key molecules involved in cell signaling in LSECs: Yes-associated protein (YAP) and connective tissue growth factor (CTGF). Interestingly, the integrin pathway was also observed to be activated in the mouse model of liver congestion. Using LSECs grown in the laboratory, the research team demonstrated that increased hydrostatic pressure (like that which occurs during chronic liver congestion) activates YAP through integrin αV, thereby upregulating CTGF. The team also revealed that inhibiting integrin αV or knocking out CTGF in LSECs leads to improved outcomes in the mouse model of liver congestion.
How do these results apply to humans? In single-cell and spatial transcriptomic analyses of liver samples from patients with chronic liver congestion, the researchers found the same pattern that they had seen in mice. YAP was activated in LSECs, leading to increased CTGF levels, and these changes are thought to contribute to disease progression.
“Overall, we discovered that a signaling pathway – the integrin αV–YAP–CTGF pathway – in specialized liver blood vessel cells appears to connect liver congestion to fibrosis,” states Hayato Hikita, senior author of the study. “This newly identified pathway could offer a new direction for treatment.”
Given that chronic liver congestion can eventually cause serious conditions, such as liver fibrosis, portal hypertension, and liver cancer, these findings may have wide-reaching clinical benefits. Importantly, liver congestion is seen in people with congenital heart disease who have undergone the Fontan procedure, putting them at risk of congestion-related liver damage. Moreover, the increased pressure within the liver’s tiny blood vessels that occurs during chronic liver congestion also happens in liver cirrhosis. This means that the discoveries in this study could help to inform the development of new treatments not only for patients with congestion-related liver disease, but also for those with liver cirrhosis caused by other conditions.
###
The article, “Activation of the integrin αV–YAP–CTGF axis in liver sinusoidal endothelial cells promotes liver fibrogenesis, leading to portal hypertension and liver carcinogenesis in congestive hepatopathy,” was published in Gastroenterology at DOI: https://doi.org/10.1053/j.gastro.2025.11.014
About The University of Osaka
The University of Osaka was founded in 1931 as one of the seven imperial universities of Japan and is now one of Japan's leading comprehensive universities with a broad disciplinary spectrum. This strength is coupled with a singular drive for innovation that extends throughout the scientific process, from fundamental research to the creation of applied technology with positive economic impacts. Its commitment to innovation has been recognized in Japan and around the world. Now, The University of Osaka is leveraging its role as a Designated National University Corporation selected by the Ministry of Education, Culture, Sports, Science and Technology to contribute to innovation for human welfare, sustainable development of society, and social transformation.
Website: https://resou.osaka-u.ac.jp/en
END
A new study suggests that pancreatic cancer may start preparing to “hide” from the immune system long before the disease becomes full-blown cancer. Researchers found that very early, precancerous cells in the pancreas don’t spread randomly, they gather into specific clusters and create small “neighborhoods” inside the tissue. These early cell groups also seem to communicate directly with nearby immune cells in ways that may weaken the body’s ability to fight them. Using advanced tools that characterize cells at the molecular level in tissue section of the pancreas, the team discovered that immune-suppressing signals appear at these ...
Researchers have taken inspiration from nature to create a robotic wing that can sense and adapt to changes in water to deliver unparalleled stability.
Drawing on the adaptive movements of birds and fish, the wing senses disturbances in the flow of water and automatically changes its shape to adjust to these.
The team, led by the University of Southampton, hope the soft robotics and e-skin they’ve pioneered could help close the gap in manoeuvrability and efficiency between robots and animals.
In ...
Congenital aniridia is a rare disease caused, in most cases, by mutations in the PAX6 gene, which is essential for the development of ocular structures. Although the most visible feature is the total or partial absence of the iris, its effects go far beyond this, as those affected often experience focusing problems, photophobia, and various complications that may worsen over time. Now, a clinical study led by the Ocular Neurobiology Group at the Institute for Neurosciences (IN), a joint center of Miguel Hernández University ...
Tiny insects trapped in amber could tell us a great deal about their roles in past ecosystems: pollinators, parasites, predators, and prey. But how many of the insects preserved alongside each other reflect interactions during life, and how many are just unlucky coincidences? Scientists in Spain scrutinized six key samples which preserve now-extinct insects unusually well, to try to learn more about the ants that lived at the same time as the dinosaurs.
“Amber inclusions are representative of possible interactions between different organisms shaping the environment,” explained Dr Jose de la Fuente of the Institute for Game and Wildlife Research, Spain, lead author ...
Japan is an archipelago with diverse climate zones and complex topography that is prone to heavy rain and flooding. Add the growing effects of global warming, these disaster risks are heightened with an increased frequency and intensity of extreme precipitation events. Thus, predicting when and where these events might strike is crucial for future-proofing vulnerable infrastructure, especially in ...
A phase 1 clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal surgery before birth is a safe and promising approach to treat myelomeningocele, a severe form of spina bifida. This is the first time live stem cells have been used on a fetus’ damaged spine, which could potentially lead to better health outcomes for babies compared to traditional fetal surgery.
Spina bifida is a congenital condition in which the spinal cord does not develop properly, leaving part of it exposed. This can cause lifelong health challenges, including paralysis, difficulty walking, and issues with bladder and ...
URBANA, Ill. – Plastic products are ubiquitous in our food supply chain, shedding microplastics into every part of the human ecosystem. As they degrade, microplastics break down into even smaller fragments called nanoplastics — tiny particles that can affect biological molecules in ways not fully understood. In a new study, researchers at the University of Illinois Urbana-Champaign examined what happens when nanoplastics interact with Salmonella, potentially affecting food safety and human health.
“Salmonella enterica is a major foodborne ...
JACKSONVILLE, Florida — Eric Moore, M.D., medical director of Mayo Clinic International and chair of the Department of Otolaryngology in Rochester, was elected to the Mayo Clinic Board of Trustees at its quarterly meeting on Feb. 20.
"Dr. Moore is an internationally respected leader whose commitment to patients and strategic vision will be a tremendous asset to our Board of Trustees," says Gianrico Farrugia, M.D., president and CEO, Mayo Clinic. “His extensive experience and collaborative approach will help guide our strategic ...
New York University is recognized as one of the 70 top research institutions consistently home to the world’s most-cited researchers over the past five years. The analysis of “research powerhouses,” led by the analytics company Clarivate, demonstrates where research impact is most concentrated.
Since 2001, Clarivate has identified “highly cited researchers”—a group of scientists and social scientists whose research published over the last decade has demonstrated ...
Scientists are developing a new generation of polymer-based materials that could dramatically improve the removal of persistent “forever chemicals” from drinking water, according to a new review synthesizing recent advances in environmental remediation research.
Per- and polyfluoroalkyl substances, known as PFAS, are a large class of human-made chemicals used in products ranging from firefighting foams to nonstick cookware and textiles. Their extreme stability allows them to persist in the environment and accumulate in water supplies, raising growing concerns about long-term ...
